A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
PharmaMar
UNICANCER
Children's National Research Institute
Amgen
Virginia Commonwealth University
University of Iowa
Stanford University
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
INSYS Therapeutics Inc
Children's Oncology Group
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)